Nomura Asset Management CO LTD Tg Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

Previous 0 NaN%

Previous $0 NaN%

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change
Q3 2024 Nov 15, 2024	BUY	$17.21 - $25.28 $0 - $0	0 New
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $0 - $0	0 New
Q1 2024 May 13, 2024	BUY	$13.02 - $21.3 $0 - $0	0 New
Q4 2023 Feb 09, 2024	BUY	$6.68 - $18.81 $0 - $0	0 New
Q3 2023 Nov 03, 2023	BUY	$8.36 - $26.5 $0 - $0	0 New
Q2 2022 Aug 12, 2022	SELL	$3.74 - $10.66 $0 - $0	0 Closed
Q1 2022 May 13, 2022	BUY	$7.81 - $20.45 $0 - $0	0 New
Q4 2021 Feb 01, 2022	BUY	$15.2 - $35.51 $0 - $0	0 New
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $0 - $0	0 New
Q2 2021 Aug 06, 2021	BUY	$32.5 - $48.96 $0 - $0	0 New
Q1 2021 May 14, 2021	BUY	$41.61 - $54.3 $0 - $0	0 New
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $0 - $0	0 New

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.